ASPA

ASPA

Target · Metabolic enzyme

ASPA Aspartoacylase · aminoacylase 2

ASPA (aspartoacylase, also known as ASP or ACY2) is a hydrolase that catalyses the deacetylation of N-acetylaspartic acid (NAA) to acetate and L-aspartate. It helps maintain white matter in the brain, and mutations in the ASPA gene cause Canavan disease. Browse Assay Genie's current range of ASPA research reagents below, or read on for the biology behind the target.

Cytoplasm and nucleusNAA-hydrolysing enzymeMutated in Canavan disease
313 aa
Protein length
~36 kDa
Molecular weight
17p13.2
Gene locus
EC 3.5.1.15
Enzyme class
Target information

What is ASPA (aspartoacylase)?

ASPA is an enzyme that catalyses the deacetylation of N-acetylaspartic acid (NAA), releasing acetate and L-aspartate. NAA occurs at high concentration in the brain, and its hydrolysis by aspartoacylase is thought to play a significant part in maintaining intact white matter. In other tissues the enzyme acts as a scavenger of NAA from body fluids. Studies of ASPA therefore bear on both brain biochemistry and wider NAA handling in the body.

The ASPA gene encodes a cytoplasmic and nuclear protein that belongs to the AspA/AstE family, aspartoacylase subfamily. Its activity is classified under EC 3.5.1.15. Alternatively spliced transcript variants have been described for the gene. Mouse and rat both carry an orthologous gene, Aspa, which allows the enzyme to be studied in rodent models. Researchers working on this target may use an ASPA antibody, an ASPA ELISA kit or recombinant ASPA protein to examine expression and activity.

The gene has had several names. It was formerly listed as aspartoacylase (aminoacylase 2, Canavan disease), and the symbols ASP and ACY2 appear in older literature. The disease name reflects the best-established clinical link: mutations in ASPA cause Canavan disease. This connection makes the enzyme a central subject in research on NAA metabolism and white matter maintenance.

Canavan disease research

Mutations in the ASPA gene cause Canavan disease, so the enzyme is a primary focus for studying the disorder.

White matter biology

NAA is abundant in brain, and its hydrolysis by aspartoacylase is thought to help maintain intact white matter.

NAA metabolism studies

ASPA converts N-acetylaspartic acid to acetate and L-aspartate, making it a key enzyme for tracing NAA turnover.

Body fluid NAA scavenging

Outside the brain, the enzyme acts as a scavenger of NAA from body fluids, a role relevant to peripheral tissue studies.

Background

ASPA frequently asked questions

What does ASPA do?

ASPA catalyses the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA is abundant in brain, where its hydrolysis is thought to help maintain white matter. In other tissues, ASPA acts as a scavenger of NAA from body fluids.

What other names does ASPA go by?

ASPA stands for aspartoacylase. Aliases and previous symbols include ASP and ACY2, and the earlier HGNC name was aspartoacylase (aminoacylase 2, Canavan disease). The enzyme is classified as EC 3.5.1.15. Alternatively spliced transcript variants have been reported for the gene.

Is ASPA linked to disease and conserved in rodents?

Yes. Mutations in the ASPA gene cause Canavan disease. Mouse and rat each have an orthologue named Aspa, so rodent studies are possible. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other myelin, white matter and brain metabolism targets with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P45381; product specifications from Assay Genie datasheets.

ASPA Product listing